Stem Cell and Regenerative Medicine

Stem Cell and Regenerative Medicine

Open Access
ISSN: 2639-9512
Research Article

Evaluation of the Efficacy of Platelet-Rich Plasma (PRP) Combined with Hyaluronic Acid for the Treatment of Chondral Lesions in the Knee

Authors: Leandro Gregorut Lima, Francis Ribeiro de Souza, Marco Aurélio Silvério Neves, Augusto Bindilati, Cristhianne Alves de Souza Vara, Bruna Dallaqua, Edite Rodrigues de Oliveira, Jessica de Biasi Pereira, Barbara Fialho Carvalho Sampaio

DOI: 10.33425/2639-9512.1095


Abstract

Platelet-rich plasma (PRP) has been widely used as an adjunctive tool in surgical tissue repair and, more recently, as a percutaneous approach to stimulate tissue regeneration. Among its applications, PRP stands out in the treatment of musculoskeletal disorders, including knee chondral lesions, osteoarthritis, tendinopathies, and soft tissue injuries. However, robust evidence is still required to establish standardized clinical use of PRP, especially when combined with other therapies. This study aimed to evaluate the efficacy of intra-articular infiltration of PRP combined with hyaluronic acid (HA) in the treatment of knee chondral lesions. A total of 313 patients were included and evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Short Form Health Survey (SF-12 scores), with a 12-month follow-up. The results showed statistically significant improvement (p < 0.0001) at all evaluated time points, with an average gain of up to 90 points in joint function and quality of life scores by the end of follow-up. The combined PRP and HA treatment provided progressive and sustainable clinical benefits, proving to be an effective and safe alternative for chondral regeneration and symptom relief in the knee.

View / Download PDF
Citation: Leandro Gregorut Lima, Francis Ribeiro de Souza, Marco Aurélio Silvério Neves, et al. Evaluation of the Efficacy of Platelet-Rich Plasma (PRP) Combined with Hyaluronic Acid for the Treatment of Chondral Lesions in the Knee. 2025; 9(3). DOI: 10.33425/2639-9512.1095
Editor-in-Chief
Henry E. Young
Henry E. Young
Chief Executive Officer and Consultant | Dragonfly Foundation for Research and Development

View full editorial board →
Journal Metrics
Impact Factor 2.5*
Acceptance Rate 80%
Time to first decision 5-10 Days
Submission to acceptance 10-15 Days